Dark Forest Capital Management LP Mirati Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $187,377 - $278,245	5,128 New	5,128 $190,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $3,094 - $4,508	52 New	52 $4,000
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $151 - $301	-2 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $6,336 - $9,133	-48 Reduced 96.0%	2 $0
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $6,606 - $8,872	50 New	50 $9,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.